image
Healthcare - Biotechnology - NASDAQ - US
$ 24.65
-2.11 %
$ 473 M
Market Cap
-9.36
P/E
Price Target Average
302.64%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
23.15%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Structure Therapeutics Inc.
image
Wall Street analysts predict an average 1-year price target for GPCR of $99.2 , with forecasts ranging from a low of $86 to a high of $118 .
GPCR Lowest Price Target Wall Street Target
86 USD 248.88%
GPCR Average Price Target Wall Street Target
99.2 USD 302.64%
GPCR Highest Price Target Wall Street Target
118 USD 378.70%
Price
Max Price Target
Min Price Target
Average Price Target
120120100100808060604040202000Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart GPCR

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart GPCR

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart GPCR

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)20232023202420242025202520262026202720272028202820292029